Weight loss programs can help breast cancer survivors reduce risk of recurrence

NewsGuard 100/100 Score

Cancer experts are also discussing studies that show that weight loss programs can change the biological make-up of breast tissue cells - helping survivors reduce their cancer risk.

Researchers at the Concord Cancer Centre have analysed data from 110 breast cancer survivors and will present their findings at the Clinical Oncology Society of Australia Annual Scientific Meeting.

The study found that 66% of breast cancer survivors were overweight and obese, and only one in three were meeting physical activity guidelines.

Dr Melinda Irwin, Professor of Epidemiology from Yale University, is an international expert in weight loss and cancer survival. She says that emerging research is showing the importance of maintaining a healthy weight after cancer treatment.

"My research has suggested that losing weight can actually change biological markers in serum and breast tissue of women with breast cancer and may reduce the risk of recurrence," says Dr Irwin.

"For instance, our study found that C-reactive protein, a marker of chronic inflammation and associated with breast cancer mortality, is reduced by 30% when women reduce their weight by around 5%.

"We also see the insulin pathways within the breast tissue change in ways that we know are linked to lower cancer risk and mortality."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Three early-phase clinical studies show promising initial data for patients with lymphoma, gastric cancers